Progressive fibrotic interstitial lung disease
Studies & trials
- AMBOX StudyA prospective, open-label, mixed-method, crossover randomised controlled trial, assessing the effect of oxygen on quality of life for patients with fibrotic lung disease (AmbOx). This study has been published.
INJUSTIS trial
It’s not Just Idiopathic pulmonary fibrosis study. A prospective study to identify biomarkers and gene expression profiles that determine progressive fibrotic in patients with fibrosing lung disease. This study is currently recruiting.
